Psychiatry of Intellectual Disability, Agnes Unit, Leicestershire Partnership NHS Trust, Leicester, UK.
Department of Health Sciences, University of Leicester, 22-28 Princess Road W, Leicester, LE1 6TP, UK.
J Autism Dev Disord. 2018 Sep;48(9):3228-3232. doi: 10.1007/s10803-018-3569-y.
We searched the Cochrane Central Register of Controlled Trials to provide an overview of evidence from randomized controlled trials (RCTs) of therapeutic interventions for autism spectrum disorders. From the final survey (529 RCTs), the mean size was 49 participants (standard deviation 50, range 1-479, median 36, mode 40), with a sharp increase in the number of RCTs from 2008. The most frequently evaluated intervention was antipsychotic treatment (n = 44, 3006 participants). The journal with the most RCTs was the Journal of Autism and Developmental Disorders (N = 104). Most trials were small in size, emphasising the need for research groups to collaborate to generate higher quality data with greater applicability to clinical practice.
我们检索了 Cochrane 对照试验中心注册库,以提供有关自闭症谱系障碍治疗干预的随机对照试验(RCT)证据的概述。在最终调查(529 项 RCT)中,平均规模为 49 名参与者(标准差 50,范围 1-479,中位数 36,众数 40),自 2008 年以来 RCT 的数量急剧增加。评估最多的干预措施是抗精神病治疗(n=44,3006 名参与者)。RCT 数量最多的期刊是《自闭症与发育障碍杂志》(n=104)。大多数试验规模较小,这强调了研究小组需要合作,以生成更具临床实用性的高质量数据。